Ceftriaxone and Dextrose in Duplex Container en es it fr

Ceftriaxone and Dextrose in Duplex Container Brand names, Ceftriaxone and Dextrose in Duplex Container Analogs

Ceftriaxone and Dextrose in Duplex Container Brand Names Mixture

  • No information avaliable

Ceftriaxone and Dextrose in Duplex Container Chemical_Formula

C18H18N8O7S3

Ceftriaxone and Dextrose in Duplex Container RX_link

http://www.rxlist.com/cgi/generic3/ceftriax.htm

Ceftriaxone and Dextrose in Duplex Container fda sheet

Ceftriaxone_and_Dextrose_in_Duplex_Container FDA

Ceftriaxone and Dextrose in Duplex Container msds (material safety sheet)

Ceftriaxone_and_Dextrose_in_Duplex_Container MSDS

Ceftriaxone and Dextrose in Duplex Container Synthesis Reference

M. Montavon, R. Reiner, Brit. pat. Appl. 2,022,090; eidem, U.S. pat. 4,327,210 (1979, 1982 both to Hoffmann-La Roche)

Ceftriaxone and Dextrose in Duplex Container Molecular Weight

554.583 g/mol

Ceftriaxone and Dextrose in Duplex Container Melting Point

>155 oC

Ceftriaxone and Dextrose in Duplex Container H2O Solubility

No information avaliable

Ceftriaxone and Dextrose in Duplex Container State

Solid

Ceftriaxone and Dextrose in Duplex Container LogP

-1.341

Ceftriaxone and Dextrose in Duplex Container Dosage Forms

IM infusion;

Ceftriaxone and Dextrose in Duplex Container Indication

For the treatment of the infections (respiratory, skin, soft tissue, UTI, ENT) caused by S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staph

Ceftriaxone and Dextrose in Duplex Container Pharmacology

Ceftriaxone is a cephalosporin/cephamycin beta-lactam antibiotic used in the treatment of bacterial infections caused by susceptible, usually gram-positive, organisms. Ceftriaxone has in vitro activity against gram-positive and gram-negative aerobic and anaerobic bacteria. The bactericidal activity of Ceftriaxone results from the inhibition of cell wall synthesis and is mediated through Ceftriaxone binding to penicillin binding proteins (PBPs). Ceftriaxone is stable against hydrolysis by a variety of beta-lactamases, including penicillinases, and cephalosporinases and extended spectrum beta-lactamases.

Ceftriaxone and Dextrose in Duplex Container Absorption

No information avaliable

Ceftriaxone and Dextrose in Duplex Container side effects and Toxicity

No information avaliable

Ceftriaxone and Dextrose in Duplex Container Patient Information

Patient Information:

Patients should be counseled that antibacterial drugs including Ceftriaxone should only be used to
treat bacterial infections. They do not treat viral infections (eg, common cold). When Ceftriaxone
is prescribed to treat a bacterial infection, patients should be told that although it is common
to feel better early in the course of therapy, the medication should be taken exactly as directed.
Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of
the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and
will not be treatable by Ceftriaxone or other antibacterial drugs in the future.

Ceftriaxone and Dextrose in Duplex Container Organisms Affected

Enteric bacteria and other eubacteria